Clinical Trial Update: Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer

View source ↗

Summary

Clinical trial update describing a maintenance therapy study with durvalumab in stage III non-small cell lung cancer, focusing on efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Durvalumab (Imfinzi) (durvalumab)

Snippet

Sponsor: University Hospital, Brest | Conditions: Bronchial Cancer | Status: ACTIVE_NOT_RECRUITING